

Learn about Pneumovax 23 side effects, from common injection site reactions to rare serious ones, and when you should call your doctor.
If you're about to get Pneumovax 23 — or you just received it and want to know what's normal — this guide covers exactly what to expect. Like all vaccines, Pneumovax 23 can cause side effects, but most are mild and go away on their own within a day or two. Serious reactions are rare.
Here's a breakdown of common and serious side effects, who may be more at risk, and when it's time to call your doctor.
Pneumovax 23 (pneumococcal vaccine polyvalent) is a vaccine made by Merck that protects against 23 types of Streptococcus pneumoniae bacteria. These bacteria can cause serious infections including pneumonia, meningitis, and bloodstream infections (bacteremia). The vaccine is recommended for adults 50 and older and for people aged 2 and up who are at increased risk due to chronic illness or weakened immune systems.
For a deeper look at how the vaccine works, see our guide on how Pneumovax 23 works. For full details on uses and dosing, read What Is Pneumovax 23?
The most frequently reported side effects of Pneumovax 23 are mild and typically appear within hours of vaccination. They usually resolve within 1–3 days without treatment.
These side effects are generally more noticeable with revaccination (a second dose). If you've had Pneumovax 23 before and are getting a booster dose, the injection site reaction may be somewhat stronger than the first time.
Serious side effects from Pneumovax 23 are rare, but it's important to know what to watch for:
Contact your healthcare provider or seek medical attention if you experience:
If you think you're having a severe allergic reaction, call 911 or go to the nearest emergency room immediately.
Side effects in older adults are generally similar to those in younger adults. However, older adults may have a somewhat weaker immune response to the vaccine, which can mean milder side effects but also potentially less robust protection.
People with weakened immune systems — including those with HIV, cancer, organ transplants, or those taking immunosuppressive medications — can safely receive Pneumovax 23. Side effects are similar, though the immune response (and therefore some side effects) may be diminished. These patients are among those most likely to need the vaccine, as they face the highest risk from pneumococcal disease.
Pneumovax 23 is approved for high-risk children aged 2 and older. Side effects in children are similar to those in adults, with injection site reactions being the most common. Febrile seizures, while very rare, are slightly more of a concern in young children with high fevers.
Pneumovax 23 should only be given during pregnancy if clearly needed. There is limited data on use in pregnant women. The vaccine is considered safe for breastfeeding women.
Most side effects don't require treatment, but these tips can help you feel more comfortable:
Avoid strenuous exercise with the vaccinated arm for 24 hours. Most people feel completely back to normal within 1–2 days.
Pneumovax 23 is a well-established vaccine with a long safety record. The most common side effects — injection site soreness, mild fatigue, and low-grade fever — are temporary and a sign that your immune system is building protection against 23 types of pneumococcal bacteria. Serious reactions are extremely rare.
If you haven't gotten your pneumococcal vaccine yet, don't let concerns about side effects stop you. The diseases Pneumovax 23 prevents — including pneumonia, meningitis, and bloodstream infections — are far more dangerous than any vaccine side effect. Talk to your doctor or pharmacist about whether Pneumovax 23 is right for you.
Looking for Pneumovax 23 near you? Search Medfinder to check availability at local pharmacies.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.